EcoR1 Capital, LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EcoR1 Capital, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EcoR1 Capital, LLC. EcoR1 Capital, LLC is a 10% Owner in GENVEC INC ($GNVC) and a 10% Owner in ANAPTYSBIO, INC ($ANAB) and a Director in ANAPTYSBIO, INC ($ANAB) and a 10% Owner in PROTHENA CORP PUBLIC LTD CO ($PRTA) and a 10% Owner in Surface Oncology, Inc. ($SURF).
Address: 409 ILLINOIS STREET SAN FRANCISCO 94158 CA
Companies in which EcoR1 Capital, LLC is an Insider
ANAPTYSBIO, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EcoR1 Capital, LLC: Director, 10% Owner
Holdings: 7,334,624 shares
Current Value: $135,983,929
Latest Transaction: May 04 2021
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENVEC INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EcoR1 Capital, LLC: 10% Owner
Holdings: 962,055 shares
Current Value: $6,157,152
Latest Transaction: May 27 2014
$GNVC Market Capitalization: $14.75M
$GNVC Previous Close: $6.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PROTHENA CORP PUBLIC LTD CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EcoR1 Capital, LLC: 10% Owner
Holdings: 11,034,280 shares
Current Value: $546,196,860
Latest Transaction: Mar 25 2021
$PRTA Market Capitalization: $1.71B
$PRTA Previous Close: $49.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Surface Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of EcoR1 Capital, LLC: 10% Owner
Holdings: 4,701,081 shares
Latest Transaction: Sep 03 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of EcoR1 Capital, LLC
Sentiment: All, ANAB, GNVC, PRTA, SURF
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.25 | 165,000 | 3,835,755 | 7,520,424 | 7.4 M to 7.5 M (+2.24 %) |
| May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.31 | 20,800 | 484,873 | 7,355,424 | 7.3 M to 7.4 M (+0.28 %) |
| May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.16 | 35,700 | 826,816 | 7,334,624 | 7.3 M to 7.3 M (+0.49 %) |
| May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.25 | 165,000 | 3,835,755 | 7,520,424 | 7.4 M to 7.5 M (+2.24 %) |
| May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.31 | 20,800 | 484,873 | 7,355,424 | 7.3 M to 7.4 M (+0.28 %) |
| May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.16 | 35,700 | 826,816 | 7,334,624 | 7.3 M to 7.3 M (+0.49 %) |
| Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.82 | 33,800 | 805,089 | 7,298,924 | 7.3 M to 7.3 M (+0.47 %) |